Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
The combination approach was inspired by research showing that amylin and GLP-1 act on different brain regions to reduce appetite
Notably, GLP-1Rs are also expressed by intestinal intraepithelial lymphocytes (IELs), suggesting a role in immune homeostasis of the digestive system (36, 37)
With Ipamorelin, we help patients target the root causes of fatigue, poor recovery, and metabolic slowdown, creating personalized peptide plans that fit their lifestyle and goals
Unlike earlier-generation weight-management agents, retatrutide is a triple receptor agonist , meaning it simultaneously activates three distinct hormonal receptors: GLP-1 (glucagon-like peptide-1) receptor promotes insulin secretion, reduces appetite, and slows gastric emptying [9] [10] GIP (glucose-dependent insulinotropic polypeptide) receptor enhances insulin release and may improve fat metabolism [12] [13] Glucagon receptor increases energy expenditure and may reduce hepatic steatosis, as suggested by imaging data (MRI-PDFF) from Phase 2 trials, though this effect requires confirmation in larger studies [2] [5] This triple-agonist mechanism distinguishes retatrutide from agents such as semaglutide (GLP-1 only) or tirzepatide (GLP-1/GIP dual agonist), and is thought to produce more pronounced reductions in body weight and improvements in metabolic parameters
Your care team includes board-certified physicians, registered dietitians, and dedicated care coordinators who specialize in metabolic health and long-term clinical care
Stress feels heavier
US$ 22.89
US$ 24.46
US$ 20.80
US$ 23.81
US$ 22.79
US$ 26.75
US$ 26.66
